Literature DB >> 26341006

Continuous culture of Cryptosporidium parvum using hollow fiber technology.

Mary Morada1, Sangun Lee2, Leslie Gunther-Cummins3, Louis M Weiss4, Giovanni Widmer2, Saul Tzipori2, Nigel Yarlett5.   

Abstract

Diarrheal disease is a leading cause of pediatric death in economically low resource countries. Cryptosporidium spp. are the second largest member of this group and the only member for which no treatment exists. One of the handicaps to developing chemotherapy is the lack of a reproducible long-term culture method permitting in vitro drug screening beyond 48 h. We have adapted the well-established hollow fiber technology to provide an environment that mimics the gut by delivering nutrients and oxygen from the basal layer upwards while allowing separate redox and nutrient control of the lumen for parasite development. Using this technique, oocyst production was maintained for >6 months, producing approximately 1×10(8)oocysts ml(-1)day(-1), compared with 48 h with a yield of 1×10(6)oocysts ml(-1) in two-dimensional cultures. Oocysts, after 4 and 20 weeks in culture, produced a chronic infection in a TCR-α-deficient mouse model. In vivo infectivity of oocysts was confirmed using oocysts from a 6 week culture in a dexamethasone immunosuppressed mouse model.
Copyright © 2015 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaerobic; Cryptosporidium; Hollow-fiber; In vitro culture

Mesh:

Substances:

Year:  2015        PMID: 26341006     DOI: 10.1016/j.ijpara.2015.07.006

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  43 in total

1.  Generating and Maintaining Transgenic Cryptosporidium parvum Parasites.

Authors:  Mattie C Pawlowic; Sumiti Vinayak; Adam Sateriale; Carrie F Brooks; Boris Striepen
Journal:  Curr Protoc Microbiol       Date:  2017-08-11

Review 2.  Laboratory Diagnosis of Parasites from the Gastrointestinal Tract.

Authors:  Lynne S Garcia; Michael Arrowood; Evelyne Kokoskin; Graeme P Paltridge; Dylan R Pillai; Gary W Procop; Norbert Ryan; Robyn Y Shimizu; Govinda Visvesvara
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

Review 3.  Recent advances in genetic manipulation of Cryptosporidium.

Authors:  Sumiti Vinayak
Journal:  Curr Opin Microbiol       Date:  2020-11-05       Impact factor: 7.934

4.  Genomic Variation in IbA10G2 and Other Patient-Derived Cryptosporidium hominis Subtypes.

Authors:  Per Sikora; Sofia Andersson; Jadwiga Winiecka-Krusnell; Björn Hallström; Cecilia Alsmark; Karin Troell; Jessica Beser; Romanico B G Arrighi
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

5.  Two- and Three-Dimensional Bioengineered Human Intestinal Tissue Models for Cryptosporidium.

Authors:  Daviel Cardenas; Seema Bhalchandra; Hymlaire Lamisere; Ying Chen; Xi-Lei Zeng; Sasirekha Ramani; Umesh C Karandikar; David L Kaplan; Mary K Estes; Honorine D Ward
Journal:  Methods Mol Biol       Date:  2020

6.  Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis.

Authors:  Sangun Lee; Melanie Ginese; Gillian Beamer; Hillary R Danz; Donald J Girouard; Susan P Chapman-Bonofiglio; Minhee Lee; Matthew A Hulverson; Ryan Choi; Grant R Whitman; Kayode K Ojo; Samuel L M Arnold; Wesley C Van Voorhis; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

7.  Gut-microbiota-on-a-chip: an enabling field for physiological research.

Authors:  Grissel Trujillo-de Santiago; Matías José Lobo-Zegers; Silvia Lorena Montes-Fonseca; Yu Shrike Zhang; Mario Moisés Alvarez
Journal:  Microphysiol Syst       Date:  2018-10-16

8.  Novel Bioengineered Three-Dimensional Human Intestinal Model for Long-Term Infection of Cryptosporidium parvum.

Authors:  Maria A DeCicco RePass; Ying Chen; Yinan Lin; Wenda Zhou; David L Kaplan; Honorine D Ward
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

9.  Long-term in vitro Culture of Cryptosporidium parvum.

Authors:  Nigel Yarlett; Mary Morada
Journal:  Bio Protoc       Date:  2018-08-05

10.  The Cryptosporidium parvum C-Type Lectin CpClec Mediates Infection of Intestinal Epithelial Cells via Interactions with Sulfated Proteoglycans.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.